Pharmaceutical firms to downsize production and wholesaling units

Korea’s pharmaceutical companies are likely to trim their production and wholesaling sectors as part of restructuring to counter rising raw materials prices and higher manufacturing costs.

A whirlpool of production reduction looms large in the nation's major manufacturers in a desperate effort to minimize stockpiles amid a severe domestic economic slowdown.

"Overstocked products are the b...